These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pharmacological basis of antihypertensive drug therapy]. Kolck UW; Zaugg CE; Erne P Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836 [TBL] [Abstract][Full Text] [Related]
4. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011 [TBL] [Abstract][Full Text] [Related]
5. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. Schmieder RE; Martus P; Klingbeil A JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of antihypertensive drug responses. Schwartz GL; Turner ST Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896 [TBL] [Abstract][Full Text] [Related]
7. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
8. [Individual sensitivity to antihypertensive drugs: genetic aspects]. Minushkina LO; Zateĭshchikov DA; Sidorenko BA Kardiologiia; 2005; 45(7):58-65. PubMed ID: 16091664 [TBL] [Abstract][Full Text] [Related]
9. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325 [TBL] [Abstract][Full Text] [Related]
10. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
11. Hypertension: are beta-blockers and diuretics appropriate first-line therapies? Wilson MD; Weart CW Ann Pharmacother; 1994 May; 28(5):617-25. PubMed ID: 7915151 [TBL] [Abstract][Full Text] [Related]
12. Selecting antihypertensive medication in patients with essential hypertension in Malaysia. Ong HT; Rozina G Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313 [No Abstract] [Full Text] [Related]
13. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review. Brewster LM; Seedat YK BMC Med; 2013 May; 11():141. PubMed ID: 23721258 [TBL] [Abstract][Full Text] [Related]
20. New and emerging drug treatments for hypertension. Krum H; Pellizzer AM Aust Fam Physician; 1998 Apr; 27(4):235-7, 240-2. PubMed ID: 9581329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]